Reply to rijnders and slobbe and to donnelly and leeflang

Clinical Infectious Diseases

Volumn 50, Issue 7, 2010, Pages 1071-1073

  Maertens, Johan ^a   Theunissen, Koen ^b   Lagrou, Katrien ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b VIRGA JESSE HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOMANNAN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ASPERGILLUS FUMIGATUS; HEMATOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LETTER; LUNG ASPERGILLOSIS; LUNG INFILTRATE; LUNG LAVAGE; MYCOBACTERIUM; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; ZYGOMYCETES;

EID: 77749326580     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651162     Document Type: Letter

References (6)

1. Rijnders BJA, Slobbe L. Bronchoalveolar lavage fluid galactomannan for diagnosis of invasive pulmonary aspergillosis [letter]. Clin Infect Dis 2010; 50:1070 (in this issue).
2. Cordonnier C, Botterel R Ben Amor R, et al. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. Clin Microbiol Infect 2009; 15: 81-86.
3. Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177:27-34.
4. Maertens J, Maertens V, Theunissen K, et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009;49:1688-1693.
5. Lagrou K, De Vleeschouwer J, Meersseman W, et al. Triazole resistance among clinical Aspergillus fumigatus isolates. In: Program and abstracts of the 3rd Advances Against Aspergillosis Meeting (Miami Beach, FL). 2008. Abstract 33.
6. Donnelly JP, Leeflang MM. Galactomannan detection and diagnosis invasive aspergillosis [letter]. Clin Infect Dis 2010; 50:1070-1071 (in this issue).